NO329003B1 - Anvendelse av minst en forbindelse ved fremstilling av et medikament for undertrykkelse av en immunrespons - Google Patents

Anvendelse av minst en forbindelse ved fremstilling av et medikament for undertrykkelse av en immunrespons Download PDF

Info

Publication number
NO329003B1
NO329003B1 NO20014382A NO20014382A NO329003B1 NO 329003 B1 NO329003 B1 NO 329003B1 NO 20014382 A NO20014382 A NO 20014382A NO 20014382 A NO20014382 A NO 20014382A NO 329003 B1 NO329003 B1 NO 329003B1
Authority
NO
Norway
Prior art keywords
compound
group
reaction
mmol
immunosuppressive
Prior art date
Application number
NO20014382A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014382D0 (no
NO20014382L (no
Inventor
Takayuki Yamazaki
Fumio Sugawara
Keisuke Ohta
Kazuyoshi Masaki
Kotaro Nakayama
Kengo Sakaguchi
Noriyuki Sato
Hiroeki Sahara
Tatsuya Fujita
Original Assignee
Toyo Suisan Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Suisan Kaisha filed Critical Toyo Suisan Kaisha
Publication of NO20014382D0 publication Critical patent/NO20014382D0/no
Publication of NO20014382L publication Critical patent/NO20014382L/no
Publication of NO329003B1 publication Critical patent/NO329003B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20014382A 1999-03-11 2001-09-10 Anvendelse av minst en forbindelse ved fremstilling av et medikament for undertrykkelse av en immunrespons NO329003B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6520899 1999-03-11
JP17688199 1999-06-23
PCT/JP2000/001231 WO2000053190A1 (fr) 1999-03-11 2000-03-02 Nouveaux immunodepresseurs

Publications (3)

Publication Number Publication Date
NO20014382D0 NO20014382D0 (no) 2001-09-10
NO20014382L NO20014382L (no) 2001-11-09
NO329003B1 true NO329003B1 (no) 2010-07-19

Family

ID=26406336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014382A NO329003B1 (no) 1999-03-11 2001-09-10 Anvendelse av minst en forbindelse ved fremstilling av et medikament for undertrykkelse av en immunrespons

Country Status (14)

Country Link
EP (1) EP1172108B1 (de)
JP (1) JP3771446B2 (de)
KR (1) KR100473935B1 (de)
CN (1) CN1155391C (de)
AT (1) ATE285240T1 (de)
AU (1) AU765950B2 (de)
CA (1) CA2364446C (de)
DE (1) DE60016908T2 (de)
DK (1) DK1172108T3 (de)
EA (1) EA003098B1 (de)
ES (1) ES2234568T3 (de)
NO (1) NO329003B1 (de)
PT (1) PT1172108E (de)
WO (1) WO2000053190A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2362903C (en) 1999-02-26 2006-06-13 Toyo Suisan Kaisha, Ltd. Novel sulfofucosylacylglycerol derivatives and use thereof as medicaments
DE60032470T2 (de) 1999-02-26 2007-10-11 Toyo Suisan Kaisha, Ltd. Heilmittel die sulfopyranosylacylglycerolderivate enthalten
JP3740017B2 (ja) 1999-02-26 2006-01-25 東洋水産株式会社 新規なスルホラムノシルアシルグリセロール誘導体およびその医薬としての用途
CA2452530C (en) * 2001-07-09 2008-11-18 Toyo Suisan Kaisha, Ltd. Novel immunosuppressive agent
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AU2008278337B2 (en) * 2007-07-20 2011-09-29 Toyo Suisan Kaisha, Ltd. Novel sulfonated sugar compound and use thereof as medicine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2872694B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 血管内血液凝固症候群の治療剤
JP2872695B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 腎炎の治療剤
JPH07242691A (ja) * 1994-01-17 1995-09-19 Sankyo Co Ltd １位にカルボキシメチレン基を有する４−ホスホノグルコサミン類
JP4454051B2 (ja) * 1997-01-24 2010-04-21 東洋水産株式会社 新規な糖脂質、その製造方法及びその用途
FR2774094B1 (fr) * 1998-01-26 2001-04-13 Ifremer Procede de purification de sulfoquinovosyldiacylglycerol par chromatographie de partage centrifuge

Also Published As

Publication number Publication date
DE60016908T2 (de) 2005-12-08
CA2364446C (en) 2007-09-25
EA200100967A1 (ru) 2002-02-28
KR100473935B1 (ko) 2005-03-08
DK1172108T3 (da) 2005-02-07
CN1155391C (zh) 2004-06-30
EP1172108A4 (de) 2003-10-15
ATE285240T1 (de) 2005-01-15
EA003098B1 (ru) 2002-12-26
CA2364446A1 (en) 2000-09-14
CN1343121A (zh) 2002-04-03
WO2000053190A1 (fr) 2000-09-14
DE60016908D1 (de) 2005-01-27
KR20020005613A (ko) 2002-01-17
AU2825500A (en) 2000-09-28
JP3771446B2 (ja) 2006-04-26
NO20014382D0 (no) 2001-09-10
NO20014382L (no) 2001-11-09
EP1172108A1 (de) 2002-01-16
PT1172108E (pt) 2005-02-28
ES2234568T3 (es) 2005-07-01
EP1172108B1 (de) 2004-12-22
AU765950B2 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
US7378398B2 (en) Method for treating cancer
JPWO2000051622A1 (ja) スルホピラノシルアシルグリセロール誘導体を含有する医薬
EP1172108B1 (de) Verwendung von Sulfoquinovosyldiacylglycerol Derivativen als Immunosuppresssiva
US6518410B2 (en) Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
JPWO2000053190A1 (ja) 新規な免疫抑制剤
US6759522B2 (en) Sulforhamnosylacyglycerol derivatives and use thereof as medicaments
AU2001269486B2 (en) Novel immunosuppressants
US6740640B2 (en) Sulfofucosylacylglycerol derivatives and administration thereof as medicaments

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees